CliffBio
biologic

Micrhogam, Rhogam

Rho(D) Immune Globulin (Human)

Loss of exclusivityApril 2010projected — 12-year biologic exclusivity estimate
CompanyKedrion Biopharma, Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameMicrhogam, Rhogam
Active ingredientRho(D) Immune Globulin (Human)
Strength300UG
Dosage formInjection
RouteIntramuscular
ModalityBiologic
FDA approvalApril 1998
Marketing statusRx

More from Kedrion Biopharma, Inc.

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Micrhogam, Rhogam patent cliff — loss of exclusivity April 2010 | CliffBio